[Immune response to Epstein-Barr virus in patients with otorhinolaryngologic neoplasms of various morphology and invasiveness].
Both nasopharyngeal and tumors and epithelial cancer of topographically different sites of the mouth, laryngopharynx are shown to be associated in many cases with high immunity to virus Epstein-Barr (VEB) antigens. VEB-associated antibody quantitation in patients with laryngeal, laryngopharyngeal, oral and lingual cancer revealed that the malignant process dissemination and the tumor differentiation are related to immune response to VEB antigens: the more advanced is cancer and the poorer is its differentiation, the more pronounced is the immune response.
Isaeva
T M
TM
Choĭnozonov
E L
EL
Podoplekin
V D
VD
D000914:Antibodies, Viral / Q000097:blood / Q000276:immunology; D000937:Antigen-Antibody Reactions; D000956:Antigens, Viral / Q000097:blood / Q000276:immunology; D016022:Case-Control Studies; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D009062:Mouth Neoplasms / Q000097:blood / Q000276:immunology* / Q000473:pathology; D009367:Neoplasm Staging; D010039:Otorhinolaryngologic Neoplasms / Q000097:blood / Q000276:immunology* / Q000473:pathology
D000914:Antibodies, Viral; D000956:Antigens, Viral
Osobennosti immunnogo otveta k virusu Epshteĭna-Barr u bolńykh s opukholiami LOR-organov v zavisimosti ot rasprostranennosti i morfologicheskoĭ formy opukholi.